ADIL Insider Trading

Insider Ownership Percentage: 5.24%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Adial Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Adial Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adial Pharmaceuticals Share Price & Price History

Current Price: $1.02
Price Change: +0.30 (1.20%)
As of 11/21/2024 01:00 AM ET

This chart shows the closing price history over time for ADIL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Adial Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/29/2023Kevin SchuylerDirectorBuy700$2.74$1,918.00700View SEC Filing Icon  
11/29/2021William B. Stilley, IIICEOBuy400$64.75$25,900.00View SEC Filing Icon  
11/26/2021James W. Newman, Jr.DirectorBuy400$71.25$28,500.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adial Pharmaceuticals (NASDAQ:ADIL)

16.41% of Adial Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADIL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Adial Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2024Renaissance Technologies LLC34,346$39K0.0%-32.8%0.811%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC20,469$27K0.0%N/A0.484%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC159,000$0.30M0.0%N/A9.578%Search for SEC Filing on Google Icon
11/9/2023Manchester Capital Management LLC48,097$0.13M0.0%-96.0%3.942%Search for SEC Filing on Google Icon
5/9/2023Manchester Capital Management LLC1,202,452$0.42M0.1%N/A4.216%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC77,694$27K0.0%+142.7%0.301%Search for SEC Filing on Google Icon
8/2/2022Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088%Search for SEC Filing on Google Icon
7/22/2022Truist Financial Corp33,862$45K0.0%N/A0.142%Search for SEC Filing on Google Icon
7/13/2022Private Advisor Group LLC21,400$29K0.0%-37.3%0.090%Search for SEC Filing on Google Icon
11/12/2021Oppenheimer & Co. Inc.38,500$0.17M0.0%+37.5%0.190%Search for SEC Filing on Google Icon
11/12/2021NorthRock Partners LLC10,000$43K0.0%N/A0.049%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC36,461$0.16M0.0%+25.5%0.180%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC31,038$79K0.0%N/A0.153%Search for SEC Filing on Google Icon
8/16/2021State Street Corp48,954$0.13M0.0%N/A0.260%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp21,873$56K0.0%N/A0.116%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC88,246$0.23M0.0%+13.2%0.469%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112%Search for SEC Filing on Google Icon
8/11/2021Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155%Search for SEC Filing on Google Icon
8/3/2021Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152%Search for SEC Filing on Google Icon
7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC15,850$38K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/12/2021Rede Wealth LLC15,000$36K0.0%N/A0.086%Search for SEC Filing on Google Icon
5/10/2021Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126%Search for SEC Filing on Google Icon
4/22/2021Private Advisor Group LLC36,650$89K0.0%N/A0.212%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC98,900$0.17M0.0%+6.5%0.687%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC18,902$42K0.0%N/A0.131%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Adial Pharmaceuticals logo
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Read More on Adial Pharmaceuticals

Today's Range

Now: $1.02
Low: $1.00
High: $1.02

50 Day Range

MA: $1.02
Low: $0.94
High: $1.17

52 Week Range

Now: $1.02
Low: $0.77
High: $4.17

Volume

56,707 shs

Average Volume

2,631,707 shs

Market Capitalization

$6.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Adial Pharmaceuticals?

Adial Pharmaceuticals' top insider shareholders include:
  1. Kevin Schuyler (Director)
Learn More about top insider investors at Adial Pharmaceuticals.